Aim: To investigate an "optimal" therapeutic management of patients with papillary thyroid microcarcinoma (PTMC). Methods: We evaluated a group of 403 consecutive patients affected by PTMC operated on by the same surgeon. Prognostic factors were evaluated by uni- and multivariate statistical analysis. Results: After a mean follow-up of 8.5 years, 372 patients were living without disease (undetectable serum thyroglobulin levels), 24 patients were living with disease (increased serum thyroglobulin levels), 6 patients were deceased due to causes different from thyroid cancer, and 1 patient was deceased due to metastatic thyroid cancer. No statistically significant prognostic factor was found at uni- and multivariate analysis. However, it is worth noting that in patients with a larger primary tumour (size ≥ 5 mm) and treated by partial thyroidectomy alone, the prevalence of recurrent disease was higher than in patients treated by total thyroidectomy and 131I administration. Conclusion: It appears reasonable to perform total thyroidectomy (possibly associated with central compartment node dissection), 131I whole body scan (followed by 131I therapy when necessary) and TSH-suppressive hormonal therapy in patients with PTMC. © 2006 Elsevier Ltd. All rights reserved.

Pelizzo M.R., Boschin I.M., Toniato A., Piotto A., Bernante P., Pagetta C., et al. (2006). Papillary thyroid microcarcinoma (PTMC): Prognostic factors, management and outcome in 403 patients. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 32(10), 1144-1148 [10.1016/j.ejso.2006.07.001].

Papillary thyroid microcarcinoma (PTMC): Prognostic factors, management and outcome in 403 patients

Bernante P.;
2006

Abstract

Aim: To investigate an "optimal" therapeutic management of patients with papillary thyroid microcarcinoma (PTMC). Methods: We evaluated a group of 403 consecutive patients affected by PTMC operated on by the same surgeon. Prognostic factors were evaluated by uni- and multivariate statistical analysis. Results: After a mean follow-up of 8.5 years, 372 patients were living without disease (undetectable serum thyroglobulin levels), 24 patients were living with disease (increased serum thyroglobulin levels), 6 patients were deceased due to causes different from thyroid cancer, and 1 patient was deceased due to metastatic thyroid cancer. No statistically significant prognostic factor was found at uni- and multivariate analysis. However, it is worth noting that in patients with a larger primary tumour (size ≥ 5 mm) and treated by partial thyroidectomy alone, the prevalence of recurrent disease was higher than in patients treated by total thyroidectomy and 131I administration. Conclusion: It appears reasonable to perform total thyroidectomy (possibly associated with central compartment node dissection), 131I whole body scan (followed by 131I therapy when necessary) and TSH-suppressive hormonal therapy in patients with PTMC. © 2006 Elsevier Ltd. All rights reserved.
2006
Pelizzo M.R., Boschin I.M., Toniato A., Piotto A., Bernante P., Pagetta C., et al. (2006). Papillary thyroid microcarcinoma (PTMC): Prognostic factors, management and outcome in 403 patients. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 32(10), 1144-1148 [10.1016/j.ejso.2006.07.001].
Pelizzo M.R.; Boschin I.M.; Toniato A.; Piotto A.; Bernante P.; Pagetta C.; Rampin L.; Rubello D.
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/913545
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 112
  • ???jsp.display-item.citation.isi??? 107
social impact